Price
Target price
€17.10
€17.10
-0.580%
-0.1
-0.580%
€12.06
19.07.24 / Frankfurt
WKN: A1WZ6P / Symbol: PAHC / Name: Phibro Animl / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Phibro Animal Health Corp. A Stock
Phibro Animal Health Corp. A shows a slight decrease today, losing -€0.100 (-0.580%) compared to yesterday.
Based on 3 Buy predictions and 2 Sell predictions the sentiment towards Phibro Animal Health Corp. A is rather balanced.
However, we have a potential of -29.82% for Phibro Animal Health Corp. A as the target price of 12 € is below the current price of 17.1 €.
Pros and Cons of Phibro Animal Health Corp. A in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Phibro Animal Health Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp. A | -0.580% | 7.547% | 4.268% | 31.538% | 66.019% | -18.571% | -36.348% |
| Rockwell Medical Inc. | -2.220% | -11.523% | -0.116% | -52.288% | -0.807% | -75.739% | -93.713% |
| Gritstone Oncology Inc | 0.770% | 1.427% | -11.307% | -67.941% | -67.492% | -91.052% | - |
| Pacira Pharmaceuticals | -5.260% | -9.091% | -31.298% | -45.122% | -39.597% | -63.115% | -48.820% |
Comments
Phibro Animal Health Co. (NASDAQ: PAHC) had its price target raised by analysts at Barclays PLC from $10.00 to $13.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Co. (NASDAQ: PAHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Co. (NASDAQ: PAHC) is now covered by analysts at BNP Paribas. They set an "underperform" rating and a $9.00 price target on the stock.
Show more
Ratings data for PAHC provided by MarketBeat